Paradigm Biocapital Advisors LP Q3 2024 Filing

Filed November 14, 2024

Portfolio Value

$2955.9T

Holdings

31

Report Date

Q3 2024

Filing Type

13F-HR

All Holdings (31 positions)

#StockSharesValue% PortfolioType
1
NUVLNUVALENT INC
5,000,000$511.5T17.30%
2
ACLXARCELLX INC
4,800,000$400.8T13.56%Call
3
ARGXARGENX SE
480,374$260.4T8.81%
4
RVMDREVOLUTION MEDICINES INC
5,314,089$241.0T8.15%
5
CRNXCRINETICS PHARMACEUTICALS IN
2,516,686$128.6T4.35%
6
MRUSMERUS N V
2,454,917$122.6T4.15%
7
JANXJANUX THERAPEUTICS INC
2,400,574$109.1T3.69%
8
PCVXVAXCYTE INC
904,532$103.4T3.50%Call
9
KURAKURA ONCOLOGY INC
4,331,321$84.6T2.86%
10
TARSTARSUS PHARMACEUTICALS INC
2,440,445$80.3T2.72%
11
EWTXEDGEWISE THERAPEUTICS INC
2,789,172$74.4T2.52%
12
IRONDISC MEDICINE INC
1,497,720$73.6T2.49%
13
VRDNVIRIDIAN THERAPEUTICS INC
2,895,689$65.9T2.23%
14
OLMAOLEMA PHARMACEUTICALS INC
5,503,600$65.7T2.22%
15
ARVNARVINAS INC
2,339,961$57.6T1.95%
16
YMABUSDY-MABS THERAPEUTICS INC
4,086,346$53.7T1.82%
17
COGTCOGENT BIOSCIENCES INC
4,609,762$49.8T1.68%
18
VERAVERA THERAPEUTICS INC
1,096,851$48.5T1.64%
19
MLTXMOONLAKE IMMUNOTHERAPEUTICS
931,480$47.0T1.59%
20
ONCBEIGENE LTD
200,336$45.0T1.52%
21
IMTXIMMATICS N.V
3,904,862$44.6T1.51%
22
APGEAPOGEE THERAPEUTICS INC
701,817$41.2T1.39%
23
IMVTIMMUNOVANT INC
1,362,827$38.9T1.31%
24
CGEMCULLINAN THERAPEUTICS INC
2,321,013$38.9T1.31%
25
SYRESPYRE THERAPEUTICS INC
1,267,581$37.3T1.26%
26
PLRXPLIANT THERAPEUTICS INC
3,104,486$34.8T1.18%
27
KROSKEROS THERAPEUTICS INC
525,037$30.5T1.03%
28
ERASERASCA INC
10,668,141$29.1T0.99%
29
ORKAORUKA THERAPEUTICS INC
719,660$17.6T0.60%
30
CATXPERSPECTIVE THERAPEUTICS INC
919,692$12.3T0.42%
31
CMPSCOMPASS PATHWAYS PLC
1,160,000$7.3T0.25%